Description
Latin name
HAEMODEZ-N
Release form
The solution for infusion is clear, light yellow or yellow.
Pharmacological action
A drug with a detoxifying effect. The mechanism of action is due to the ability of low molecular weight povidone to bind toxins circulating in the blood and quickly remove them from the body.
Hemodez-H enhances renal blood flow, increases glomerular filtration, and increases diuresis.
Hemodez-H differs from hemodez by the lower molecular weight of polyvinylpyrrolidone used to make it. The decrease in the molecular weight of the polymer accelerates its excretion by the kidneys from the body and improves the detoxification properties of the drug.
Indications
Detoxification therapy for:
toxic forms of acute infectious intestinal diseases (dysentery, salmonellosis)
peritonitis (in the postoperative period)
liver diseases accompanied by the development of hepatic disease
Intrauterine infection and toxemia of the newborn.
Contraindications
² hemorrhagic stroke
² cardiovascular insufficiency
² increased sensitivity to the drug.
Use during pregnancy and lactation
Data on the efficacy and safety of the use of the drug Hemodez-H during pregnancy during lactation are not provided.
Special instructions
In case of allergic reactions during drug administration, immediately stop the infusion and conduct symptomatic therapy (antihistamines, cardiotonics, glucocorticosteroids, vasoconstrictor drugs).
The occurrence of adverse reactions with the introduction of Hemodez-H at an increased rate may require the introduction of vasoconstrictor and cardiotonic drugs, calcium chloride
100 ml
sodium chloride 900 mg g
sodium chloride 550 mg
potassium chloride 42 mg
calcium chloride 50 mg
magnesium chloride anhydrous 500 mcg
sodium bicarbonate 23 mg
osmolarity 214 mosm
Excipients: water d / i.
Dosage and administration
Before administration, the solution should be warmed to body temperature.
The drug is administered intravenously at a rate of 40-80 drops / min. A single dose depends on the age of the patient and the severity of intoxication. The initial dose for children is 2.5 ml / kg body weight.
The maximum single dose depending on the patient’s age is presented in the table:
Patient age Maximum single dose
up to 1 year 50 ml
2-5 years 70 ml
6-9 years 100 ml
10-15 years 200 ml
adults 400 ml
The drug is administered 1-2 times / day depending on the severity of intoxication.
Side effects
Possible: (when administered at an increased rate) – arterial hypotension, tachycardia, shortness of breath.
In some cases: allergic reactions up to anaphylactic shock.
Drug interaction
Drug drug interaction not described.
Overdose
Data on overdose with Hemodesis-H are not provided.
Storage conditions
The product should be stored out of the reach of children at 0 ° to 20 ° C. Freezing the drug and wetting the inner surface of the bottles is not a contraindication to the use of the drug. Expiration – 3 years.
active substance
Povidone
Pharmacy terms
Prescription
lekarstvennaja form
Solution for infusion
Appointment
Adults doctor’s prescription
Possible product names
Gemodez-N infusion solution 200 ml vials
Kursk Biofa Briok-firm Biok, Russia
